文献速递眼底病与葡萄膜炎

五种OCTA设备与荧光素血管造影在视网膜微动脉瘤可视化中的比较

Microaneurysms visualisation using five different optical coherence tomography angiography devices compared to fluorescein angiography.
PubMed 文献 · Br J Ophthalmol · 2020-06-11

FA检出的微动脉瘤数量显著高于所有OCTA设备;Spectralis OCTA检出数显著高于其他四种OCTA设备(p<0.0001),且灵敏度最高(43.3%)但特异度最低(54.4%),DRI OCT Triton特异度(78.5%)和阳性预测值(83.3%)最高。结论认为FA仍是可视化视网膜微动脉瘤的最佳成像方式,OCTA设备间的高变异性在临床实践和未来临床试验中应予考虑。

要点

  • FA检出的视网膜微动脉瘤数量显著高于所有五种OCTA设备。
  • Spectralis OCTA检出微动脉瘤数显著多于其他四种OCTA设备(p<0.0001)。
  • DRI OCT Triton特异度(78.5%)和阳性预测值(83.3%)最高,Spectralis OCTA灵敏度最高(43.3%)但特异度最低(54.4%)。

核心结论

  • FA仍是可视化视网膜微动脉瘤的最佳成像方式。
  • Spectralis OCTA检出微动脉瘤数多于其他OCTA设备,可能与扫描区域内B扫描数量更多及重复B扫描次数更多有关。
  • OCTA设备间的高变异性在临床实践和未来临床试验中应予考虑。

研究设计与样本

  • 所有OCTA设备均采用3×3体积扫描模式,分别评估浅层毛细血管丛(SCP)和深层毛细血管丛(DCP)的微动脉瘤。

主要发现

  • FA检出的微动脉瘤数量显著高于OCTA设备。
  • Spectralis OCTA检出的微动脉瘤数量显著高于PlexElite、RTVue XR Avanti、AngioPlex和DRI OCT Triton(p<0.0001)。
  • PlexElite和AngioPlex在SCP显示更多微动脉瘤,Spectralis OCTA、RTVue XR Avanti和DRI OCT Triton在DCP显示更多微动脉瘤。
  • Spectralis OCTA灵敏度最高(43.3%)但特异度最低(54.4%),DRI OCT Triton特异度(78.5%)和阳性预测值(83.3%)最高。

关键数值与推荐

  • Spectralis OCTA灵敏度43.3%、特异度54.4%。
  • DRI OCT Triton特异度78.5%、阳性预测值83.3%。
  • Spectralis OCTA与其他四种OCTA设备微动脉瘤检出数比较的p<0.0001。

临床怎么用

  • 临床评估糖尿病视网膜病变微动脉瘤时,需注意FA与OCTA及不同OCTA设备间检出数量和诊断准确性的差异。
  • 选择OCTA设备观察微动脉瘤时,应考虑设备间的高变异性,尤其Spectralis OCTA灵敏度较高但特异度较低。

局限性

  • 原文未报告研究的具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To compare fluorescein angiography (FA) and five different optical coherence tomography angiography (OCTA) devices and to test their reproducibility in the evaluation of retinal microaneurysms (MAs) secondary to diabetic retinopathy (DR). METHODS: On the same day, patients with DR were imaged with FA and five OCTA devices: prototype Spectralis OCTA, prototype PlexElite, RTVue XR Avanti, AngioPlex and DRI OCT Triton. For all OCTA devices, a 3×3 volume scan pattern was performed. MAs were evaluated for the superficial capillary plexus (SCP) and deep capillary plexus (DCP). RESULTS: Twenty eyes of 15 patients with DR were included. FA counted a significantly higher number of MAs compared to OCTA devices. Spectralis OCTA obtained a significantly higher number of MAs compared to PlexElite, RTVue XR Avanti, AngioPlex and DRI OCT Triton (p<0.0001). PlexElite and AngioPlex showed a greater number of MAs in the SCP, Spectralis OCTA, RTVue XR Avanti and DRI OCT Triton in the DCP. Higher sensitivity (43.3%) but lowest specificity (54.4%) was observed for Spectralis OCTA compared to other devices. The higher specificity (78.5%) and positive predictive value (83.3%) were observed for DRI OCT Triton. CONCLUSIONS: FA remains the best imaging modality to visualise retinal MAs. Spectralis OCTA was able to detect more MAs compared to other devices, likely due to the higher number of B-scans in the scanned area as well as due to the higher number of repeated B-scans. The high variability between OCTA devices should be taken into account for future clinical trials as in clinical practice.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Parrulli S, Corvi F, Cozzi M, et al. Microaneurysms visualisation using five different optical coherence tomography angiography devices compared to fluorescein angiography. Br J Ophthalmol. 2020. PMID: 32527718. doi:10.1136/bjophthalmol-2020-316817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。